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Abstract
Confronting the SARS-CoV-2 outbreak has allowed us to appreciate how efficiently highly-resourced settings can respond 
to crises. However even such settings are not prepared to deal with the situation, and lessons are only slowly being learnt. 
There is still an urgent need to accelerate protocols that lead to the implementation of rapid point-of-care diagnostic test-
ing and effective antiviral therapies. In some high-risk populations, such as dialysis patients, where several individuals are 
treated at the same time in a limited space and overcrowded areas, our objective must be to ensure protection to patients, 
the healthcare team and the dialysis ward. The difficult Italian experience may help other countries to face the challenges. 
The experience of the Lombardy underlines the need for gathering and sharing our data to increase our knowledge and sup-
port common, initially experience-based, and as soon as possible evidence-based position to face this overwhelming crisis.
Background
The recent infection caused by SARS-CoV-2, a new strand 
of the Coronavirus, is challenging healthcare systems world-
wide. Italy is one of the countries in which the infection 
has spread most rapidly and where the number of deaths is 
steadily increasing [1].
The initial Italian policy has been one of extensive test-
ing of suspected cases including their contacts, and while 
this may have increased the efficacy of preventive measures, 
it has contributed to spreading concern. The lack of pre-
cise knowledge about the natural history of the disease, the 
awareness that even non-symptomatic or oligo-symptomatic 
cases (which probably account for about half of the individu-
als testing positive for the virus) may spread the infection, 
and the fact that re-infection is possible, further complicate 
the situation [2–4].
In common with other viral diseases, mortality is higher 
in elderly patients with high comorbidity, but no age is 
spared, and the impressive figures of transmission in dif-
ferent communities underline the need for reorganization of 
efforts to limit contagion, particularly in crowded settings 
[5].
Proximity and comorbidity require special attention 
[6–8]. In this context some populations, such as dialysis 
patients, combine fragility with the need for care in settings 
in which several individuals are treated at the same time.
Dialysis patients have a less efficient immune system 
and are more prone to develop severe infectious dis-
eases than the general population [9–10]. In the case of 
the SARS-CoV-2, the few data available in the literature 
referring specifically to dialysis patients suggest that 
the inflammatory reaction may be less violent and, as a 
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consequence, patients on dialysis may have mild clinical 
signs, at least in the early stages of the disease, with a 
higher risk of diffusing the infection in the dialysis ward 
[11].
The Lombardy experience
In Lombardy, where the first severe infectious outbreak 
in Italy occurred at the time of this report, two dialysis 
centers were deeply involved. In the first, a satellite hemo-
dialysis center where 60 patients were being treated, 18 
were infected and immediately isolated. About one week 
elapsed between the first patient and the eighteenth. Dur-
ing this time, the nephrology unit was transformed into an 
isolation unit and the 18 patients were treated in a small, 
dedicated dialysis ward set up to deal with the emergency, 
separated from the main dialysis ward. Of the 18 patients 
with clinical infection one is in critical condition but so 
far does not need respiratory assistance. So far none of the 
healthcare staff has been infected.
The rigidly implemented isolation measures were 
effective and no other patient (out of a total of about 200 
patients on hemodialysis) has developed a clinical picture 
thereafter. In the second center, 50 km away, 4 of its 170 
patients were found to be infected. They were promptly 
isolated and no other case has been diagnosed. None 
of the staff was infected. Both centers are being closely 
monitored. In both centers the tests were performed only 
in symptomatic cases; in both units, since the first posi-
tive case, all patients have been required to wear surgi-
cal masks from the time they arrive in the hemodialysis 
waiting room and while waiting for swab tests results the 
healthcare team applies the rules that would be followed 
if the case were to be confirmed (see below).
Basic, pragmatic suggestions
To limit the spread of the infection in dialysis centers, it is 
advisable to act on two fronts: healthcare team and patients 
(Table 1).
Healthcare team: the goal is to involve and inform the 
healthcare team so that they do not underestimate the risk 
of infection, considering that dialysis patients can have sub-
tle manifestations [11]. In this case prevention has multiple 
objectives: avoiding the spread of infection from patient to 
patient; preventing nurses and physicians from contracting 
the infection; avoiding the collapse of healthcare services 
that would ensue if a high number of healthcare personnel 
had to be quarantined.
Because healthcare-associated transmission and infec-
tion of healthcare workers are a major problem, the Center 
for Disease Control in the United States recommend that 
healthcare workers use personal protective equipment (PPE) 
and implement standard, contact, and airborne precautions 
including eye protection. The indications are however not 
fully clear, and may differ across countries [11].
Dialysis patients: The goal is timely identification of 
affected patients so that they can be isolated, keeping in 
mind that clinical manifestations can be subtle (general 
malaise, fatigue, low fever and cold or flu-like manifesta-
tions), at least in the early stages of the disease.
The general measures and specific interventions that 
make it possible to accomplish these goals are set forth 
below.
General measures
The first step is to insist that staff observe individual protec-
tive measures, which involve rules that should be routine 
practice in all dialysis centers.
Table 1  The three main goals for limiting the spread of Coronavirus in the dialysis ward
Action 1 Protect patients Dialysis patients are vulnerable to infectious diseases and, even though the clinical picture may be non-spe-
cific, due to uremia related immune-suppression, SARS-CoV 2 infection may impair the fragile balance of 
these individuals. Prompt diagnosis is a protection for the whole dialysis ward. Systematic use of surgical 
masks helps reduce transmission and limit stress
Action 2 Protect the team Nursing and medical staff are at high risk for nosocomial infections; protecting the team also protects a 
unit’s overall activity, especially in settings in which shortages of physicians and nurses are already criti-
cal [12]. Nursing shortages should be prevented by all means, including recruitment of retired nurses, or 
rapid training of young ones
Action 3 Protect the dialysis ward The dialysis ward is a setting at high risk for infectious outbreaks; the dialysis procedure is time consuming, 
and the extracorporeal circuit is a risk element; the management of the arteriovenous fistula is likewise 
critical. The decision to keep positive patients out of the dialysis ward as much as possible, especially at a 
time when patients are stressed, nurses are working under pressure, and members of the healthcare team 
may be ill or in quarantine, protects the dialysis ward and makes it possible to protect patients and staff
Journal of Nephrology 
1 3
(A) Dispensers of alcoholic solutions should be installed 
in waiting rooms and all patients should be told to use 
them.
(B) Hemodialysis patients should be told to wash their 
hands and fistula arm before starting dialysis and 
should thoroughly disinfect the puncture areas.
(C) Whenever possible, a short evaluation should be made 
before a patient is allowed to enter the dialysis ward and 
body temperature should be systematically measured.
(D) Nursing and medical staff working in dialysis rooms 
should wear surgical masks and protective glasses, 
wash their hands with soap and water and systemati-
cally use alcoholic solutions and disposable gloves. 
Surgical masks should be changed every 4–6 h, accord-
ing to type and producer’s instructions.
(E) Nursing and medical staff should be tested at least upon 
the appearance of symptoms, whose definition should 
be as broad as possible. Testing contacts may be useful, 
but depends upon availability of the tests.
(F) Patients with a cough, fever (of whatever entity, taking 
into account the fact that the febrile reaction may be 
blunted in dialysis patients), upper airway involvement 
or conjunctivitis should be evaluated before they are 
allowed to entry into the dialysis ward.
(G) It is advisable that each center organizes an isolated 
area (unless the hospital has provided an alternative 
path) for allowing evaluation and testing of these 
patients.
(H) All patients with suspected signs or symptoms should 
be tested, keeping in mind the possible subtle manifes-
tation of the disease.
(I) Whenever possible, all patients should wear a surgi-
cal mask. In case of shortage, protection should be 
reserved to
Advice and management of the various 
possible cases
Hemodialysis patients from so-called "active" areas, or those 
who have been in contact with people who tested positive 
(considering an incubation time of about 15 days):
1. Absence of manifestations of disease:
  Besides the rigorous observance of the recommended 
rules mentioned above, even in settings in which short-
age of masks is a problem, these patients should wear 
a surgical mask from the time they arrive at the center 
until they leave, therefore for the entire duration of the 
dialysis session.
  In the case of patients who have been in contact with 
family members or caregivers with suspect or signs of 
SARS-CoV-2 infection, the minimum requirement is a 
surgical mask. Testing should be proposed as much as 
possible, but will be probably decided on a case-by-case 
basis (availability of the test, risk factors, logistic situa-
tion of the dialysis center).
2. Patients with fever and signs of airways infection:
  According to the rules defined in each setting, the 
patient must be sent to the emergency room, or to a dedi-
cated area, isolated from the dialysis ward, for evalua-
tion and work-up before dialysis.
  If the infectious disease specialist decides to carry out 
a nasopharyngeal swab, there are 3 possible situations:
(a) While waiting for the result, the patient should be 
treated as if affected by SARS-CoV-2;
  if dialysis cannot be postponed, whenever pos-
sible, the patient must be hospitalized and dia-
lyzed in a room equipped for dialysis treatment. 
If mobile dialysis water preparation devices are 
available, they should be previously connected 
in one or two rooms in the infectious diseases 
ward or where hospitalization and treatment can 
be safely carried out. According to the center’s 
experience, a CRRT machine or a portable hemo-
dialysis machine can be considered as alternatives.
  For the dialysis care of these cases, health pro-
fessionals should wear the personal protection 
advised for infected cases.
(b) If the outcome of the swab is positive, the patient 
must remain in isolation and the operators in con-
tact with the patient must be equipped as above.
  Due to the complexity of the management of 
dialysis patients, their fragility, their risk of sud-
den decompensating, we suggest, whenever pos-
sible, hospitalizing them until recovery.
  Recovery after SARS-CoV-2 infection has to be 
certified, according to the current indications.
(c) If the outcome of the swab is negative, the patients 
can return to the dialysis facility.
3. In case of respiratory distress or failure ER staff must be 
summoned immediately, since the need for mechanical 
ventilation may be sudden.
4. Patients on peritoneal dialysis should be assisted at 
home as far as possible, using telereporting assistance 
or other systems for communication whenever possible 
(e.g. WhatsApp, video, etc.).
5. It is important to underline that:
  In the wait for a curative treatment or an effective 
vaccine, protection barriers are the best means for mini-
mizing the impact of the epidemic [13].
In case of peripheral centers without the possibility 
of isolation, and where an infectious disease unit, and an 
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intensive care unit are not available, patients with suspect 
or confirmed disease should be centralized in hospitals that 
have these requirements.
Conclusions
Confronting the SARS-CoV-2 outbreak has allowed us to 
appreciate how efficiently highly-resourced settings can 
respond to crises. However even such settings are not pre-
pared to deal with the situation, and lessons are only slowly 
being learnt. There is still an urgent need to accelerate pro-
tocols that lead to the implementation of rapid point-of-care 
diagnostic testing and effective antiviral therapies.
In some high-risk populations, such as dialysis patients, 
where several individuals are treated at the same time in a 
limited space and overcrowded areas, our objective must be 
to ensure protection to patients, the healthcare team and the 
dialysis ward.
The difficult Italian experience may help other countries 
to face the challenges. The experience of the Lombardy 
underlines the need for gathering and sharing our data to 
increase our knowledge and support common, initially 
experience-based, and as soon as possible evidence-based 
position to face this overwhelming crisis.
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